These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 33471400)

  • 21. In vivo vulnerability to competition by endogenous dopamine: comparison of the D2 receptor agonist radiotracer (-)-N-[11C]propyl-norapomorphine ([11C]NPA) with the D2 receptor antagonist radiotracer [11C]-raclopride.
    Narendran R; Hwang DR; Slifstein M; Talbot PS; Erritzoe D; Huang Y; Cooper TB; Martinez D; Kegeles LS; Abi-Dargham A; Laruelle M
    Synapse; 2004 Jun; 52(3):188-208. PubMed ID: 15065219
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Increased dopamine D2(High) receptors in amphetamine-sensitized rats, measured by the agonist [(3)H](+)PHNO.
    Seeman P; McCormick PN; Kapur S
    Synapse; 2007 May; 61(5):263-7. PubMed ID: 17318886
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Estimating endogenous dopamine levels at D2 and D3 receptors in humans using the agonist radiotracer [(11)C]-(+)-PHNO.
    Caravaggio F; Nakajima S; Borlido C; Remington G; Gerretsen P; Wilson A; Houle S; Menon M; Mamo D; Graff-Guerrero A
    Neuropsychopharmacology; 2014 Nov; 39(12):2769-76. PubMed ID: 24874713
    [TBL] [Abstract][Full Text] [Related]  

  • 24. In vitro and in vivo comparison of [³H](+)-PHNO and [³H]raclopride binding to rat striatum and lobes 9 and 10 of the cerebellum: a method to distinguish dopamine D₃ from D₂ receptor sites.
    Kiss B; Horti F; Bobok A
    Synapse; 2011 Jun; 65(6):467-78. PubMed ID: 20936685
    [TBL] [Abstract][Full Text] [Related]  

  • 25. D2 receptor occupancy in conscious rat brain is not significantly distinguished with [3H]-MNPA, [3H]-(+)-PHNO, and [3H]-raclopride.
    Peng T; Zysk J; Dorff P; Elmore CS; Ström P; Malmquist J; Ding M; Tuke D; Werkheiser J; Widzowski D; Mrzljak L; Maier D
    Synapse; 2010 Aug; 64(8):624-33. PubMed ID: 20340171
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dopamine D2High receptors measured ex vivo are elevated in amphetamine-sensitized animals.
    Seeman P
    Synapse; 2009 Mar; 63(3):186-92. PubMed ID: 19086090
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A Preliminary Investigation of the Effect of Acute Alcohol on Dopamine Transmission as Assessed by [
    Thiruchselvam T; Wilson AA; Boileau I; Le Foll B
    Alcohol Clin Exp Res; 2017 Jun; 41(6):1112-1119. PubMed ID: 28421623
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Reward motivation in humans and its relationship to dopamine D
    Caravaggio F; Fervaha G; Browne CJ; Gerretsen P; Remington G; Graff-Guerrero A
    J Psychopharmacol; 2018 Mar; 32(3):357-366. PubMed ID: 29442593
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Amphetamine-induced dopamine release in rat: Whole-brain spatiotemporal analysis with [
    Johansson J; Ericsson M; Axelsson J; Bjerkén SA; Virel A; Karalija N
    J Cereb Blood Flow Metab; 2024 Mar; 44(3):434-445. PubMed ID: 37882727
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The D2/3 dopamine receptor in pathological gambling: a positron emission tomography study with [11C]-(+)-propyl-hexahydro-naphtho-oxazin and [11C]raclopride.
    Boileau I; Payer D; Chugani B; Lobo D; Behzadi A; Rusjan PM; Houle S; Wilson AA; Warsh J; Kish SJ; Zack M
    Addiction; 2013 May; 108(5):953-63. PubMed ID: 23167711
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Endogenous dopamine release in the human brain as a pharmacodynamic biomarker: evaluation of the new GPR139 agonist TAK-041 with [
    Rabiner EA; Uz T; Mansur A; Brown T; Chen G; Wu J; Atienza J; Schwarz AJ; Yin W; Lewis Y; Searle GE; Dennison JMTJ; Passchier J; Gunn RN; Tauscher J
    Neuropsychopharmacology; 2022 Jun; 47(7):1405-1412. PubMed ID: 34675381
    [TBL] [Abstract][Full Text] [Related]  

  • 32. PET imaging of dopamine-D2 receptor internalization in schizophrenia.
    Weinstein JJ; van de Giessen E; Rosengard RJ; Xu X; Ojeil N; Brucato G; Gil RB; Kegeles LS; Laruelle M; Slifstein M; Abi-Dargham A
    Mol Psychiatry; 2018 Jun; 23(6):1506-1511. PubMed ID: 28507321
    [TBL] [Abstract][Full Text] [Related]  

  • 33. High-affinity states of human brain dopamine D2/3 receptors imaged by the agonist [11C]-(+)-PHNO.
    Willeit M; Ginovart N; Kapur S; Houle S; Hussey D; Seeman P; Wilson AA
    Biol Psychiatry; 2006 Mar; 59(5):389-94. PubMed ID: 16373068
    [TBL] [Abstract][Full Text] [Related]  

  • 34. In vivo evidence for greater amphetamine-induced dopamine release in pathological gambling: a positron emission tomography study with [(11)C]-(+)-PHNO.
    Boileau I; Payer D; Chugani B; Lobo DS; Houle S; Wilson AA; Warsh J; Kish SJ; Zack M
    Mol Psychiatry; 2014 Dec; 19(12):1305-13. PubMed ID: 24322203
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Amphetamine pretreatment blunts dopamine-induced D2/D3-receptor occupancy by an arrestin-mediated mechanism: A PET study in internalization compromised mice.
    Mandeville JB; Weigand-Whittier J; Wey HY; Chen YI
    Neuroimage; 2023 Dec; 283():120416. PubMed ID: 37866759
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Positron emission tomography imaging of amphetamine-induced dopamine release in the human cortex: a comparative evaluation of the high affinity dopamine D2/3 radiotracers [11C]FLB 457 and [11C]fallypride.
    Narendran R; Frankle WG; Mason NS; Rabiner EA; Gunn RN; Searle GE; Vora S; Litschge M; Kendro S; Cooper TB; Mathis CA; Laruelle M
    Synapse; 2009 Jun; 63(6):447-61. PubMed ID: 19217025
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Modulation of amphetamine-induced dopamine release by group II metabotropic glutamate receptor agonist LY354740 in non-human primates studied with positron emission tomography.
    van Berckel BN; Kegeles LS; Waterhouse R; Guo N; Hwang DR; Huang Y; Narendran R; Van Heertum R; Laruelle M
    Neuropsychopharmacology; 2006 May; 31(5):967-77. PubMed ID: 16177807
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Reduced insulin sensitivity is related to less endogenous dopamine at D2/3 receptors in the ventral striatum of healthy nonobese humans.
    Caravaggio F; Borlido C; Hahn M; Feng Z; Fervaha G; Gerretsen P; Nakajima S; Plitman E; Chung JK; Iwata Y; Wilson A; Remington G; Graff-Guerrero A
    Int J Neuropsychopharmacol; 2015 Feb; 18(7):pyv014. PubMed ID: 25716779
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ex vivo [11C]-(+)-PHNO binding is unchanged in animal models displaying increased high-affinity states of the D2 receptor in vitro.
    McCormick PN; Kapur S; Reckless G; Wilson AA
    Synapse; 2009 Nov; 63(11):998-1009. PubMed ID: 19598174
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Risky decision-making and ventral striatal dopamine responses to amphetamine: a positron emission tomography [(11)C]raclopride study in healthy adults.
    Oswald LM; Wand GS; Wong DF; Brown CH; Kuwabara H; Brašić JR
    Neuroimage; 2015 Jun; 113():26-36. PubMed ID: 25795343
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.